Transforming growth factor-beta-inducible gene h3 (TGFBI) hypermethylation has been shown to be associated with paclitaxel-resistance in ovarian cancer and was correlated with the loss of TGFBI mRNA expression [38]. This evidence concerns the gene TGFBI and ovarian cancer.